Lilian Silva Martins de Arruda

3PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Dec 21, 2023
Febrile neutropenia incidence and the variable toxicity profile between brand and generic docetaxel in the adjuvant treatment of breast cancer with docetaxel and cyclophosphamide regimen.

Flávia Viécili Tarcha, Ana Luísa de Castro Baccarin, Lilian Arruda do Rêgo Barros

|Nov 10, 2021
High mortality among patients with cancer and COVID-19 infection: the experience of a Brazilian cancer center.

Lilian Arruda do Rêgo Barros, Marcos Aurélio Fonseca Magalhães Filho, Rafaela de Brito Alves

|Jan 24, 2019
Hormone receptor-negative as a predictive factor for pathologic complete response to neoadjuvant therapy in breast cancer.

Luana Carolina Ferreira Fiuza Silva, Lilian Silva Martins de Arruda, Waldec Jorge David Filho

Pageof 1